Glucosidase
Glucosidase refers to a group of carbohydrate-active enzymes that hydrolyze glycosidic bonds in glucosides and oligosaccharides, producing glucose or other sugar residues.
Glucosidase refers to a group of carbohydrate-active enzymes that hydrolyze glycosidic bonds in glucosides and oligosaccharides, producing glucose or other sugar residues. The term includes enzymes with different substrate specificities and stereochemical preferences, particularly α-glucosidases and β-glucosidases, which act on α- or β-linked glucose-containing substrates, respectively. Glucosidases are found in animals, plants, fungi, and microorganisms and participate in carbohydrate digestion, intracellular glycan processing, biomass degradation, and carbohydrate metabolism.
In human physiology, intestinal α-glucosidase activity contributes to the final stages of starch and disaccharide digestion by releasing glucose for absorption. Pharmacological inhibition of α-glucosidase can delay carbohydrate breakdown and glucose absorption, thereby reducing postprandial blood-glucose excursions. This mechanism has made α-glucosidase an established target in research on type 2 diabetes, often alongside amylase, which catalyzes earlier stages of starch hydrolysis. Acarbose is a commonly used reference inhibitor in biochemical and drug-discovery studies, while metformin has also been investigated for possible competitive interactions with α-glucosidase. Inhibitor discovery commonly uses enzyme-kinetic analysis, IC50 measurements, molecular docking, and assessment of hydrophobic interactions and hydrogen bonding.
Beyond diabetes research, glucosidases are being explored as targets for carbohydrate-processing technologies and enzyme-activated therapeutics. Selective enzymatic activation has, for example, been investigated as a means of triggering controlled radical release, while simultaneous inhibition of α- and β-glucosidase and amylase has been evaluated in experimental anticancer strategies.
Where the papers sit
20 papers from the last 6 months study glucosidase directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 6 human data · 14 preclinical
Themes one subject · 1 new direction
Those 20 are all about one subject.
-
Antidiabetic Enzyme Inhibition
Novel α-glucosidase inhibitors are being advanced from computational design and synthesis toward antidiabetic validation. Coumarin-triazole, thiazolidinone, benzothiazole, pyrazole and oxadiazole derivatives are assessed alongside plant metabolites and polysaccharides, often against α-amylase as well. Metformin and natural products provide mechanistic comparisons, while in vivo hyperglycemia studies test whether enzyme inhibition translates to efficacy. Immobilized-enzyme and chemiluminescent platforms broaden screening, but potency, selectivity and clinical relevance remain open.
Glucosidase is repurposed as a trigger for therapeutic radical release rather than as an enzyme to inhibit
The alkoxyamine–carbohydrate radical prodrugs use glucosidase enzymatic specificity to cleave a carbohydrate leaving group and initiate C–O bond homolysis, generating toxic alkyl radicals for potential treatment of resistant infections. This departs from the set’s prevailing use of glucosidase as a target whose inhibition is intended to control carbohydrate digestion and postprandial glucose; the enzyme instead becomes an activation mechanism for an antimicrobial or cytotoxic prodrug platform 42593934Aug.
Papers
The 20 papers from the last 6 months that study glucosidase directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Antidiabetic Enzyme Inhibition (20)
- Aniline-linked coumarin-triazole hybrids as α-glucosidase inhibitors: An insightful study from synthesis to in vivo efficacy and mechanistic analysis. Bioorganic chemistry · 24 Oct 2026 PMID 42925716
- Computer-aided development of novel thiazolidinone-thiazole derivatives: multidimensional structure-activity relationships revealed by quantum chemical analysis, molecular docking and biological investigation. Journal of computer-aided molecular design · 16 Oct 2026 PMID 42886389
- Design, synthesis, and computational assessment of bis-oxadiazole ligands targeting α-amylase and α-glucosidase: DFT, docking, and ADME studies. Future medicinal chemistry · 18 Sept 2026 PMID 42755370
- In silico inhibition mechanism of α-amylase and α-glucosidase by fragransinic acid and bellericagenin B, two compounds from Combretum fragrans F. Hoffm (Combretaceae). Zeitschrift fur Naturforschung. C, Journal of biosciences · 4 Sept 2026 PMID 42696156
- Design, synthesis and biological evaluation of hydroxybenzothiazole-linked benzothiazole/benzoxazole conjugates as potent dual α-amylase and α-glucosidase inhibitors. Bioorganic chemistry · 30 Aug 2026 PMID 42669271
- Exolide A, structurally diverse Ent-18-norbeyerane diterpenoid from the stems of Indian mangrove plant, Excoecaria agallocha Linn. Fitoterapia · 29 Aug 2026 PMID 42668099
- Nyctanthes arbor-tristis attenuates hyperglycemia: an integrated experimental and computational investigation. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 27 Aug 2026 PMID 42658420
- Inducing Metabolic Dysfunction in Breast Cancer Cells Through Targeted Inhibition of α- and β-Glucosidase and Amylase: Novel Carbohydrate (C8N) Isomers Designed via Intramolecular aza-Michael-Type Reaction. ChemMedChem · 15 Aug 2026 PMID 42603779
- Homolysis of Alkoxyamines Triggered by Carbohydrate-Active Enzyme: A Step toward a General Platform to Generate Toxic Alkyl Radicals. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593934
- A novel hydroquinone-based chemiluminescent biosensing platform for ultrasensitive sensing of α-glucosidase activity. Biosensors & bioelectronics · 24 Jul 2026 PMID 42497548
- Structural elucidation and α-amylase/α-glucosidase inhibition properties of xyloglucan and RG-I types polysaccharides from tamarind (Tamarindus indica L.) pulp. Carbohydrate polymers · 23 Jul 2026 PMID 42493157
- Extraction-driven structural modulation dictates the anti-diabetic potency of Notopterygium franchetii polysaccharides. Carbohydrate polymers · 23 Jul 2026 PMID 42493156
- α-Glucosidase immobilization on cellulose filter paper coated with a blend of chitosan and polyvinyl alcohol for inhibitor screening from traditional Chinese medicines. Journal of pharmaceutical and biomedical analysis · 21 Jun 2026 PMID 42323927
- Identification of novel pyrazole-containing thiazolidine-2,4-dione derivatives as potent α-glucosidase inhibitors: design, synthesis and antidiabetic assessment. Bioorganic chemistry · 20 Jun 2026 PMID 42322909
- Exploring the competitive inhibition mechanism of α-glucosidase by metformin. Bioorganic chemistry · 18 Jun 2026 PMID 42314600
- Bio-guided fractionation of (9Z )-5,8,11-trihydroxyoctadec-9-enoic acid from Abelmoschus sagittifolius root as a potent α-glucosidase inhibitor: An integrated in vitro and in silico study. Journal of the science of food and agriculture · 18 Jun 2026 PMID 42310894
- Novel 1H-pyrrole-2,5-dione derivatives as potential anti-diabetic agents: design, synthesis, in vitro, in ovo, and molecular docking studies. Bioorganic & medicinal chemistry letters · 13 Jun 2026 PMID 42288313
- 2,4-thiazolidinediones as dual-target inhibitors against carbohydrate metabolism enzymes in type 2 diabetes. Bioorganic chemistry · 12 Jun 2026 PMID 42284877
- β-Maltose-conjugated acetophenone thiosemicarbazones as multitarget inhibitors of diabetes- and Alzheimer's disease-related enzymes: Design, synthesis, and mechanistic evaluation. Bioorganic chemistry · 25 May 2026 PMID 42184581
- COF-derived photocatalytic artificial enzymes-assisted precision analysis of active ingredients in natural product extracts. Talanta · 22 May 2026 PMID 42172965
By study type
Human data, design not indexed (6)
- Computer-aided development of novel thiazolidinone-thiazole derivatives: multidimensional structure-activity relationships revealed by quantum chemical analysis, molecular docking and biological investigation. Journal of computer-aided molecular design · 16 Oct 2026 PMID 42886389
- Design, synthesis, and computational assessment of bis-oxadiazole ligands targeting α-amylase and α-glucosidase: DFT, docking, and ADME studies. Future medicinal chemistry · 18 Sept 2026 PMID 42755370
- Homolysis of Alkoxyamines Triggered by Carbohydrate-Active Enzyme: A Step toward a General Platform to Generate Toxic Alkyl Radicals. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593934
- A novel hydroquinone-based chemiluminescent biosensing platform for ultrasensitive sensing of α-glucosidase activity. Biosensors & bioelectronics · 24 Jul 2026 PMID 42497548
- Exploring the competitive inhibition mechanism of α-glucosidase by metformin. Bioorganic chemistry · 18 Jun 2026 PMID 42314600
- β-Maltose-conjugated acetophenone thiosemicarbazones as multitarget inhibitors of diabetes- and Alzheimer's disease-related enzymes: Design, synthesis, and mechanistic evaluation. Bioorganic chemistry · 25 May 2026 PMID 42184581
Preclinical: animal, cell and lab studies (14)
- Aniline-linked coumarin-triazole hybrids as α-glucosidase inhibitors: An insightful study from synthesis to in vivo efficacy and mechanistic analysis. Bioorganic chemistry · 24 Oct 2026 PMID 42925716
- In silico inhibition mechanism of α-amylase and α-glucosidase by fragransinic acid and bellericagenin B, two compounds from Combretum fragrans F. Hoffm (Combretaceae). Zeitschrift fur Naturforschung. C, Journal of biosciences · 4 Sept 2026 PMID 42696156
- Design, synthesis and biological evaluation of hydroxybenzothiazole-linked benzothiazole/benzoxazole conjugates as potent dual α-amylase and α-glucosidase inhibitors. Bioorganic chemistry · 30 Aug 2026 PMID 42669271
- Exolide A, structurally diverse Ent-18-norbeyerane diterpenoid from the stems of Indian mangrove plant, Excoecaria agallocha Linn. Fitoterapia · 29 Aug 2026 PMID 42668099
- Nyctanthes arbor-tristis attenuates hyperglycemia: an integrated experimental and computational investigation. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 27 Aug 2026 PMID 42658420
- Inducing Metabolic Dysfunction in Breast Cancer Cells Through Targeted Inhibition of α- and β-Glucosidase and Amylase: Novel Carbohydrate (C8N) Isomers Designed via Intramolecular aza-Michael-Type Reaction. ChemMedChem · 15 Aug 2026 PMID 42603779
- Structural elucidation and α-amylase/α-glucosidase inhibition properties of xyloglucan and RG-I types polysaccharides from tamarind (Tamarindus indica L.) pulp. Carbohydrate polymers · 23 Jul 2026 PMID 42493157
- Extraction-driven structural modulation dictates the anti-diabetic potency of Notopterygium franchetii polysaccharides. Carbohydrate polymers · 23 Jul 2026 PMID 42493156
- α-Glucosidase immobilization on cellulose filter paper coated with a blend of chitosan and polyvinyl alcohol for inhibitor screening from traditional Chinese medicines. Journal of pharmaceutical and biomedical analysis · 21 Jun 2026 PMID 42323927
- Identification of novel pyrazole-containing thiazolidine-2,4-dione derivatives as potent α-glucosidase inhibitors: design, synthesis and antidiabetic assessment. Bioorganic chemistry · 20 Jun 2026 PMID 42322909
- Bio-guided fractionation of (9Z )-5,8,11-trihydroxyoctadec-9-enoic acid from Abelmoschus sagittifolius root as a potent α-glucosidase inhibitor: An integrated in vitro and in silico study. Journal of the science of food and agriculture · 18 Jun 2026 PMID 42310894
- Novel 1H-pyrrole-2,5-dione derivatives as potential anti-diabetic agents: design, synthesis, in vitro, in ovo, and molecular docking studies. Bioorganic & medicinal chemistry letters · 13 Jun 2026 PMID 42288313
- 2,4-thiazolidinediones as dual-target inhibitors against carbohydrate metabolism enzymes in type 2 diabetes. Bioorganic chemistry · 12 Jun 2026 PMID 42284877
- COF-derived photocatalytic artificial enzymes-assisted precision analysis of active ingredients in natural product extracts. Talanta · 22 May 2026 PMID 42172965
Written from 20 PubMed abstracts, each one listed by PMID above. Published: 2026-09-16. Drafted by language models from published abstracts; not medical advice.